http://www.akebia.com
Akebia Therapeutics, Inc. Company Intro
Fully integrated renal biopharmaceutical company with a late stage product in global Phase 3 clinical development and a commercially available medicine.
Industry
Healthcare
Akebia Therapeutics, Inc. Headquaters
245 First Street
Cambridge,02142
United States
Akebia Therapeutics, Inc. Share price
17 May 2023 12:44 GMT
$1.0700
-0.02 (-1.83 %)
Akebia Therapeutics, Inc. Market cap
$195.224 M
WMC RANKING
2023
Akebia Therapeutics, Inc. # 34
BiotechnologyLatest Akebia Therapeutics, Inc. News
30 Nov 2023
Akebia Therapeutics (NASDAQ:AKBA) Given Buy Rating at ...
Akebia Therapeutics, Inc, a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The...
30 Nov 2023
DaVita's 'Move It With Purpose' Event Achieves Record ...
2023 Move It With Purpose sponsors include AmerisourceBergen, CSL Vifor, WellDyne, Akebia Therapeutics, Baxter International Inc., Henry Schein, Inc., SoftServe...
30 Nov 2023
Is Akebia Therapeutics Inc (AKBA) a Stock to Watch After ...
Akebia Therapeutics Inc is a biopharmaceutical company. It focuses on the development and commercialization of novel therapeutics to patients with kidney...
WMC Market Score
WMC Market to Revenue Score
Akebia Therapeutics, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Akebia Therapeutics, Inc. | USD | $259,133 | $338,585 | $-392,290 | $1,952M | 34 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,197,600 | $3,997,800 | $4,003,800 | $804,390B | 1 |
| Vertex Pharmaceuticals Incorporated | USD | $6,414,881 | $2,617,257 | $2,762,032 | $878,880B | 2 |
| Alexion Pharmaceuticals, Inc. | USD | $6,261,601 | $2,747,200 | $681,800 | $ | 3 |
| Incyte Corporation | USD | $2,702,913 | $2,048,306 | $478,480 | $144,340B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Akebia Therapeutics, Inc. Social Followers vs Top 4 Industry Competitors
Akebia Therapeutics, Inc. Post vs Top 4 Industry Competitors
Akebia Therapeutics, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Akebia Therapeutics, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Akebia Therapeutics, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Akebia Therapeutics, Inc. | 2.82 | 11.69 | 0.11 | 0 | 0 | 0 | 5.09 |
| Regeneron Pharmaceuticals, Inc. | 100 | 25.50 | 16.15 | 28 | 0 | 0 | 29.94 |
| Vertex Pharmaceuticals Incorporated | 69.75 | 35.68 | 8.95 | 40 | 0 | 0 | 36.32 |
| Alexion Pharmaceuticals, Inc. | 68.08 | 100 | 100 | 32 | 0 | 0 | 100 |
| Incyte Corporation | 29.39 | 5.03 | 0.04 | 100 | 0 | 0 | 45.31 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
